The activity of the transcription factor Nuclear factor-kappa B (NF-κB) is increased in acute CNS diseases such as stroke and severe epileptic seizures, as well as in chronic neurodegenerative conditions, including AD, PD, and amyotrophic lateral sclerosis [42]. This evidence concerns the gene NFKB1 and Stroke.